K Höfner|W Dorschner - JoVE Visualize

Showing results (51-60 of 83) with videos related to

Pageof 9

Sort By:

Scandinavian Journal of Urology and Nephrology|September 1, 1995

Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing studyD Mazur, J Wehnert, W Dorschner, et al.

Neurourology and Urodynamics|March 26, 1998

Analysis of outcome after thermotherapy using different classifications of bladder outlet obstructionK Höfner, A Tubaro, J J de la Rosette, et al.

Restorative Neurology and Neuroscience|March 6, 2012

Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunctionV Grünewald, K Höfner, W F Thon, et al.

World Journal of Urology|January 1, 1995

CHESS classification of bladder-outflow obstruction. A consequence in the discussion of current conceptsK Höfner, A E Kramer, H K Tan, et al.

Current Opinion in Urology|October 13, 2006

Surgical strategy in late-stage renal cell cancer with intracaval extensionM A Kuczyk, K Höfner, C G Stief, et al.

BJU International|July 31, 2003

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitorM P O'Leary, C Roehrborn, G Andriole, et al.

European Urology|September 4, 1999

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstructionK Höfner, H Claes, T M De Reijke, et al.

Der Urologe. Ausg. A|January 1, 1996

[Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]M A Kuczyk, C Bokemeyer, J Serth, et al.

Aktuelle Urologie|October 21, 2003

[The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine]W Dorschner, J-U Stolzenburg, R Griebenow, et al.

European Urology|January 1, 1997

Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study GroupC R Chapple, L Baert, P Thind, et al.

Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:

Pageof 9

Scandinavian Journal of Urology and Nephrology|September 1, 1995

Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing studyD Mazur, J Wehnert, W Dorschner, et al.

Neurourology and Urodynamics|March 26, 1998

Analysis of outcome after thermotherapy using different classifications of bladder outlet obstructionK Höfner, A Tubaro, J J de la Rosette, et al.

Restorative Neurology and Neuroscience|March 6, 2012

Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunctionV Grünewald, K Höfner, W F Thon, et al.

World Journal of Urology|January 1, 1995

CHESS classification of bladder-outflow obstruction. A consequence in the discussion of current conceptsK Höfner, A E Kramer, H K Tan, et al.

Current Opinion in Urology|October 13, 2006

Surgical strategy in late-stage renal cell cancer with intracaval extensionM A Kuczyk, K Höfner, C G Stief, et al.

BJU International|July 31, 2003

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitorM P O'Leary, C Roehrborn, G Andriole, et al.

European Urology|September 4, 1999

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstructionK Höfner, H Claes, T M De Reijke, et al.

Der Urologe. Ausg. A|January 1, 1996

[Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status]M A Kuczyk, C Bokemeyer, J Serth, et al.

Aktuelle Urologie|October 21, 2003

[The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine]W Dorschner, J-U Stolzenburg, R Griebenow, et al.

European Urology|January 1, 1997

Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study GroupC R Chapple, L Baert, P Thind, et al.

Pageof 9